Avenue Therapeutics Inc (ATXI)
2.20
-0.04
(-1.79%)
USD |
NASDAQ |
Nov 04, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
Avenue Therapeutics Research and Development Expense (TTM): 5.642M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.642M |
| March 31, 2024 | 7.308M |
| December 31, 2023 | 10.36M |
| September 30, 2023 | 9.924M |
| June 30, 2023 | 9.211M |
| March 31, 2023 | 6.335M |
| December 31, 2022 | 2.698M |
| September 30, 2022 | 2.543M |
| June 30, 2022 | 2.627M |
| March 31, 2022 | 2.804M |
| December 31, 2021 | 1.254M |
| September 30, 2021 | 1.348M |
| June 30, 2021 | 1.536M |
| March 31, 2021 | 2.427M |
| December 31, 2020 | 2.866M |
| September 30, 2020 | 7.237M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.477M |
| March 31, 2020 | 13.65M |
| December 31, 2019 | 23.19M |
| September 30, 2019 | 21.05M |
| June 30, 2019 | 21.14M |
| March 31, 2019 | 18.50M |
| December 31, 2018 | 17.70M |
| September 30, 2018 | 20.20M |
| June 30, 2018 | 20.41M |
| March 31, 2018 | 17.11M |
| December 31, 2017 | 7.801M |
| September 30, 2017 | 2.792M |
| June 30, 2017 | 0.975M |
| March 31, 2017 | 0.949M |
| December 31, 2016 | 1.38M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.254M
Minimum
Dec 2021
23.19M
Maximum
Dec 2019
6.392M
Average
5.642M
Median
Jun 2024
Research and Development Expense (TTM) Benchmarks
| Fortress Biotech Inc | 71.93M |
| Checkpoint Therapeutics Inc | 26.77M |
| Journey Medical Corp | 12.53M |
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 22.40M |